When less is more: Updates in active surveillance and watchful waiting in the management of prostate cancer

Aust J Gen Pract. 2024 May;53(5):253-257. doi: 10.31128/AJGP-06-23-6866.

Abstract

Background: Prostate cancer is the second most common cancer among men globally. A range of management options are available for prostate cancer, including surgery, radiation therapy, hormone therapy, chemotherapy, or surveillance. Conservative strategies include active surveillance and watchful waiting, which differ in their intent.

Objective: We provide a targeted instructive management algorithm for improving understanding of conservative strategies in prostate cancer.

Discussion: Active surveillance involves close monitoring with curative intent when there is evidence of disease progression. In contrast, watchful waiting is palliative in intent and focuses on delaying treatment until symptoms or complications develop. Conservative approaches have demonstrated similar long-term oncological outcomes to radical treatment, while reducing harm from overtreatment, and maintaining quality of life by avoiding potential side effects such as urinary incontinence and erectile dysfunction. The decision to employ a conservative approach is determined by both patient and disease factors. Conservative management strategies play a vital role in the management of prostate cancer.

MeSH terms

  • Disease Progression
  • Humans
  • Male
  • Prostatic Neoplasms* / therapy
  • Quality of Life / psychology
  • Watchful Waiting* / methods